228 related articles for article (PubMed ID: 29460201)
1. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Stepanova M; Nader F; Bureau C; Adebayo D; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rossi S; MacDonald S; Capel J; Jalan R; Younossi ZM
Qual Life Res; 2018 Jun; 27(6):1513-1520. PubMed ID: 29460201
[TBL] [Abstract][Full Text] [Related]
2. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
[TBL] [Abstract][Full Text] [Related]
3. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
Wong F; Bendel E; Sniderman K; Frederick T; Haskal ZJ; Sanyal A; Asrani SK; Capel J; Kamath PS
Liver Transpl; 2020 May; 26(5):651-661. PubMed ID: 31999044
[TBL] [Abstract][Full Text] [Related]
4. Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial.
Pereira RA; Virella D; Perdigoto R; Marcelino P; Saliba F; Germano N
Trials; 2023 Aug; 24(1):534. PubMed ID: 37582719
[TBL] [Abstract][Full Text] [Related]
5. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
6. Automated low-flow ascites pump in a real-world setting: complications and outcomes.
Solbach P; Höner Zu Siederdissen C; Wellhöner F; Richter N; Heidrich B; Lenzen H; Kerstin P; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1082-1089. PubMed ID: 29738325
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].
Choi CH; Han KH; Kim DY; Cho JH; Cheong JY; Song KH; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):52-60. PubMed ID: 12499817
[TBL] [Abstract][Full Text] [Related]
8. Surgical technique for placement of the automated low flow ascites pump (Alfapump).
Dembinski J; Aranovich D; Banz V; Ehmann T; Klein I; Malago M; Richter N; Schnitzbauer AA; Staszewicz W; Tautenhahn HM; Capel J; Regimbeau JM
Langenbecks Arch Surg; 2020 Feb; 405(1):117-123. PubMed ID: 31915920
[TBL] [Abstract][Full Text] [Related]
9. Consensus care recommendations for alfapump
Aagaard NK; Malago M; De Gottardi A; Thomas M; Sauter G; Engelmann C; Aranovich D; Cohen M; Thévenot T; Ehmann T; Capel J; Angeli P; Jalan R; Stirnimann G
BMC Gastroenterol; 2022 Mar; 22(1):111. PubMed ID: 35260086
[TBL] [Abstract][Full Text] [Related]
10. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory Ascites.
Bendel EC; Sniderman K; Shaw C; Frederick RT; Wong F; Sanyal A; Asrani SK; Kamath PS; Capel J; Haskal ZJ
J Vasc Interv Radiol; 2020 Aug; 31(8):1256-1262.e3. PubMed ID: 32654961
[TBL] [Abstract][Full Text] [Related]
13. Current management of refractory ascites in patients with cirrhosis.
Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
[TBL] [Abstract][Full Text] [Related]
14. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
15. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy.
Campbell MS; Brensinger CM; Sanyal AJ; Gennings C; Wong F; Kowdley KV; McCashland T; Reddy KR
Hepatology; 2005 Sep; 42(3):635-40. PubMed ID: 16108073
[TBL] [Abstract][Full Text] [Related]
18. Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites.
Fotopoulou C; Berg T; Hausen A; Hennig R; Jalan R; Malagó M; Capel J; De Gottardi A; Stirnimann G
BMC Palliat Care; 2019 Dec; 18(1):109. PubMed ID: 31805921
[TBL] [Abstract][Full Text] [Related]
19. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
Pose E; Cardenas A
Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.
Wong YJ; Lum HM; Tan PT; Teo EK; Tan J; Kumar R; Thurairajah PH
Singapore Med J; 2021 Dec; 62(12):659-664. PubMed ID: 33866716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]